Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 44NIH 3OTHER_GOV 2INDUSTRY 2FED 1

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Insulin Resistance 1

Interventions

Inositol 6follitropin alfa 4Glycoprotein Hormones, alpha Subunit 3follitropin beta 2Metformin 2Letrozole 2DLBS3233 2Clomiphene 2Chorionic Gonadotropin 2licogliflozin 1elagolix 1cetrorelix 1Urofollitropin 1Secretome 1Progesterone 1Oils 1Menotropins 1Leuprolide 1Lactalbumin 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Folic Acid 1Diosgenin 1Contraceptives, Oral 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Polycystic Ovary Syndrome × Clomiphene × Clear all
NCT06507332 2024-07-18

Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone

Egymedicalpedia

Phase NA Unknown
64 enrolled

Polycystic Ovary Syndrome

NCT01638988 2015-07-28

Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin

Clinique Ovo

Phase 3 Withdrawn

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡